A document, according to the FDA, that contains “a summary of the safety and effectiveness data and information evaluated by FDA during the drug approval process.” (21CFR314.430) Sponsors may draft the Summary Basis of Approval; it may also be written by FDA scientists.
« Back to Glossary Index